COMMUNIQUÉ DE PRESSE publié le 18/05/2026 à 12:00, il y a 5 mois 30 jours PAL Next AG: Annual General Meeting Supports Strategic Realignment with Company Renaming and Election of New Supervisory Board PAL Next AG's Annual General Meeting supports strategic realignment with company renaming and election of new Supervisory Board in Munich. Company's future positioning enhanced through operational developments and AI integration AI Integration Annual General Meeting Supervisory Board Strategic Realignment PAL Next AG
BRÈVE publiée le 31/03/2026 à 07:35, il y a 7 mois 17 jours PAL Next AG atteint des objectifs de revenus et renforce sa situation financière en 2025 Croissance Des Revenus PAL Next AG Résultats Financiers 2025 Renforcement Du Capital Production D'IA
BRÈVE publiée le 31/03/2026 à 07:35, il y a 7 mois 17 jours PAL Next AG Achieves Revenue Milestones and Strengthens Financial Position in 2025 Revenue Growth Capital Strengthening PAL Next AG 2025 Financial Results AI Production
COMMUNIQUÉ DE PRESSE publié le 31/03/2026 à 07:30, il y a 7 mois 17 jours PAL Next AG: Business Performance in 2025 in Line with Plan PAL Next AG reports business performance in 2025 meeting expectations with improved equity ratio. Successful production exploitation and AI advancements noted Revenue Business Performance Equity Ratio 2025 PAL Next AG
BRÈVE publiée le 26/02/2026 à 15:05, il y a 8 mois 19 jours PAL Next AG passe du cinéma à une stratégie d'investissement plus large Stratégie D'investissement Diversification PAL Next AG Changement De Modèle D'entreprise Secteur Du Divertissement
BRÈVE publiée le 26/02/2026 à 15:05, il y a 8 mois 19 jours PAL Next AG Shifts From Film to Broad Investment Strategy Investment Strategy Diversification Entertainment Sector PAL Next AG Business Model Change
COMMUNIQUÉ DE PRESSE publié le 26/02/2026 à 15:00, il y a 8 mois 19 jours EQS-Adhoc: PAL Next AG Transitions Its Business Model to an Investment Strategy PAL Next AG transitions its business model to an investment strategy. The company aims to expand its investment focus to other industries, analyzing potential target sectors and reviewing strategic options Investment Strategy Strategic Options PAL Next AG Business Model Transition Target Sectors
BRÈVE publiée le 21/01/2026 à 12:35, il y a 9 mois 27 jours PAL Next AG annule l'apport de créance en nature Stratégie D'entreprise Industrie Du Divertissement PAL Next AG Contribution À La Créance L'IA Au Cinéma
BRÈVE publiée le 21/01/2026 à 12:35, il y a 9 mois 27 jours PAL Next AG Cancels Contribution of Receivable as Contribution in Kind Entertainment Industry Corporate Strategy PAL Next AG Receivable Contribution AI In Film
COMMUNIQUÉ DE PRESSE publié le 21/01/2026 à 12:30, il y a 9 mois 27 jours PAL Next AG: Contribution of receivable as contribution in kind will not be implemented PAL Next AG decides not to implement the contribution of a receivable as a non-cash contribution as previously announced, with discussions ongoing. Company specializes in AI-focused film and series production Entertainment AI PAL Next AG Receivable Non-cash Contribution
Publié le 17/11/2026 à 07:40, il y a 7 heures 49 minutes SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.
Publié le 17/11/2026 à 07:36, il y a 7 heures 53 minutes SUEZ INTERNATIONAL SAS A RÉALISÉ LA CESSION D’ENVIRON 10,65 MILLIONS D’ACTIONS D’ACEA
Publié le 17/11/2026 à 07:30, il y a 8 heures PR_Carrefour reaffirms its confidence in the hypermarket model, a pillar of its performance
Publié le 17/11/2026 à 07:30, il y a 8 heures CP_Carrefour réaffirme sa conviction dans le modèle de l’hypermarché, pilier de sa performance
Publié le 17/11/2026 à 06:55, il y a 8 heures 35 minutes Recticel Group door TIME erkend als een van 's werelds beste bedrijven voor duurzame groei 2027
Publié le 17/11/2026 à 15:00, il y a 30 minutes Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Publié le 17/11/2026 à 14:45, il y a 45 minutes NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
Publié le 17/11/2026 à 14:00, il y a 1 heure 30 minutes FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
Publié le 17/11/2026 à 14:00, il y a 1 heure 30 minutes Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
Publié le 17/11/2026 à 15:20, il y a 9 minutes Danske Bank Fair Fund Opens Claims Process to Compensate Eligible Investors in Danske ADRs and Common Stock
Publié le 17/11/2026 à 15:16, il y a 13 minutes REPLOID and PreZero join forces on larvae processing in a joint venture: Insect protein for the animal feed industry
Publié le 17/11/2026 à 15:13, il y a 16 minutes EQS-Adhoc: REPLOID Group AG: Joint venture with PreZero for insect protein production with revised ownership stakes